A Controlled Trial of Sertraline in Young Children With Fragile X Syndrome.
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Sertraline (Primary)
- Indications Fragile X syndrome
- Focus Therapeutic Use
- 27 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Aug 2015 Planned End Date changed from 1 Dec 2014 to 1 Sep 2015 as per ClinicalTrials.gov record.
- 13 Aug 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.